BPG is committed to discovery and dissemination of knowledge
Articles in Press
9/5/2024 7:15:27 AM | Browse: 26 | Download: 0
Category |
Oncology |
Manuscript Type |
Letter to the Editor |
Article Title |
Conversion therapy for unresectable hepatocellular carcinoma: Advances and challenges
|
Manuscript Source |
Invited Manuscript |
All Author List |
Yan-Fei He |
Funding Agency and Grant Number |
|
Corresponding Author |
Yan-Fei He, MD, Associate Chief Physician, Doctor, Department of Health Management Center, The Sixth Medical Center, Chinese People’s Liberation Army General Hospital, NO. 6 Fucheng Road, Haidian District, Beijing 100048, China. heyanfeilc@163.com |
Key Words |
Unresectable hepatocellular carcinoma; Conversion therapy; Challenges; Advances; Advanced hepatocellular carcinoma; Targeted therapy; Immunotherapy |
Core Tip |
This letter reviews recent advances in conversion therapy for hepatocellular carcinoma (HCC), comparatively describes the characteristics of different conversion programs, addresses current challenges in conversion therapy, highlights the complexity of conversion therapy for moderately advanced HCC, and emphasizes the importance of a multidisciplinary, team-based management model, and provides valuable insights into the treatment of unresectable HCC. |
Citation |
He YF. Conversion therapy for unresectable hepatocellular carcinoma: Advances and challenges. World J Gastrointest Oncol 2024; In press |
|
Received |
|
2024-03-02 03:59 |
|
Peer-Review Started |
|
2024-03-02 03:59 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-08-17 19:51 |
|
Revised |
|
2024-08-29 07:56 |
|
Second Decision |
|
2024-09-05 02:40 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2024-09-05 07:15 |
|
Articles in Press |
|
2024-09-05 07:15 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
|
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345